MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1192/j.eurpsy.2024.1765

Медицинская библиотека · European psychiatry : the journal of the Association of European Psychiatrists · 2024

Intestinal permeability biomarkers in patients with schizophrenia: Additional support for the impact of lifestyle habits.

González-Blanco Leticia, Dal Santo Francesco, García-Portilla Maria Paz, Alfonso Miqueu, Hernández Carla, Sánchez-Autet Mónica, Anmella Gerard, Amoretti Silvia, Safont Gemma, Martín-Hernández David, Malan-Müller Stefanie, Bernardo Miquel, Arranz Belén

СтатьяНаблюдательное исследованиеМногоцентровое исследованиеПеревод в очереди

Аннотация

BACKGROUND

Emerging evidence suggests a potential association between "leaky gut syndrome" and low-grade systemic inflammation in individuals with psychiatric disorders, such as schizophrenia. Gut dysbiosis could increase intestinal permeability, allowing the passage of toxins and bacteria into the systemic circulation, subsequently triggering immune-reactive responses. This study delves into understanding the relationship between plasma markers of intestinal permeability and symptom severity in schizophrenia. Furthermore, the influence of lifestyle habits on these intestinal permeability markers was determined.

METHODS

Biomarkers of intestinal permeability, namely lipopolysaccharide-binding protein (LBP), lipopolysaccharides (LPS), and intestinal fatty acid binding protein (I-FABP), were analyzed in 242 adult schizophrenia patients enrolled in an observational, cross-sectional, multicenter study from four centers in Spain (PI17/00246). Sociodemographic and clinical data were collected, including psychoactive drug use, lifestyle habits, the Positive and Negative Syndrome Scale to evaluate schizophrenia symptom severity, and the Screen for Cognitive Impairment in Psychiatry to assess cognitive performance.

RESULTS

Results revealed elevated levels of LBP and LPS in a significant proportion of patients with schizophrenia (62% and 25.6%, respectively). However, no statistically significant correlation was observed between these biomarkers and the overall clinical severity of psychotic symptoms or cognitive performance, once confounding variables were controlled for. Interestingly, adherence to a Mediterranean diet was negatively correlated with I-FABP levels (beta = -0.186, t = -2.325, p = 0.021), suggesting a potential positive influence on intestinal barrier function.

CONCLUSIONS

These findings underscore the importance of addressing dietary habits and promoting a healthy lifestyle in individuals with schizophrenia, with potential implications for both physical and psychopathological aspects of the disorder.

Для цитирования: González-Blanco Leticia, Dal Santo Francesco, García-Portilla Maria Paz, Alfonso Miqueu, Hernández Carla, Sánchez-Autet Mónica, Anmella Gerard, Amoretti Silvia, Safont Gemma, Martín-Hernández David, Malan-Müller Stefanie, Bernardo Miquel, Arranz Belén. Intestinal permeability biomarkers in patients with schizophrenia: Additional support for the impact of lifestyle habits.. European psychiatry : the journal of the Association of European Psychiatrists. 2024. DOI: 10.1192/j.eurpsy.2024.1765.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.